Advertisement

Table of Contents

December 18, 2014; 124 (26)

INSIDE BLOOD COMMENTARIES

PERSPECTIVES

EVIDENCE-BASED FOCUSED REVIEW

HOW I TREAT

CLINICAL TRIALS AND OBSERVATIONS

  • Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial
    Dieter Hoelzer, Jan Walewski, Hartmut Döhner, Andreas Viardot, Wolfgang Hiddemann, Karsten Spiekermann, Hubert Serve, Ulrich Dührsen, Andreas Hüttmann, Eckhard Thiel, Jolanta Dengler, Michael Kneba, Markus Schaich, Ingo G. H. Schmidt-Wolf, Joachim Beck, Bernd Hertenstein, Albrecht Reichle, Katarzyna Domanska-Czyz, Rainer Fietkau, Heinz-August Horst, Harald Rieder, Stefan Schwartz, Thomas Burmeister and Nicola Gökbuget for the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia
  • Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial
    Peter W. Collins, Guy Young, Karin Knobe, Faraizah Abdul Karim, Pantep Angchaisuksiri, Claus Banner, Türkiz Gürsel, Johnny Mahlangu, Tadashi Matsushita, Eveline P. Mauser-Bunschoten, Johannes Oldenburg, Christopher E. Walsh and Claude Negrier for the paradigm 2 Investigators

HEMATOPOIESIS AND STEM CELLS

IMMUNOBIOLOGY

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

PLATELETS AND THROMBOPOIESIS

RED CELLS, IRON, AND ERYTHROPOIESIS

THROMBOSIS AND HEMOSTASIS

TRANSPLANTATION

  • HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation
    Effie W. Petersdorf, Theodore A. Gooley, Mari Malkki, Andrea P. Bacigalupo, Anne Cesbron, Ernette Du Toit, Gerhard Ehninger, Torstein Egeland, Gottfried F. Fischer, Thibaut Gervais, Michael D. Haagenson, Mary M. Horowitz, Katharine Hsu, Pavel Jindra, Alejandro Madrigal, Machteld Oudshoorn, Olle Ringdén, Marlis L. Schroeder, Stephen R. Spellman, Jean-Marie Tiercy, Andrea Velardi, Campbell S. Witt, Colm O’Huigin, Richard Apps and Mary Carrington for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation

CONTINUING MEDICAL EDUCATION (CME) QUESTIONS

  • Hydroxyurea therapy